Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Invested Capital (2009 - 2025)

Grifols' (GIFLF) quarterly Invested Capital came in at $16.7 billion in Q4 2025, down 2.52% on a YoY basis from $17.2 billion in Q4 2024, and down 2.52% quarter-over-quarter from $17.2 billion in Q4 2024.

Analysis

Grifols (GIFLF) Invested Capital (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Invested Capital for 17 consecutive years, with $16.7 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital fell 2.52% year-over-year to $16.7 billion; the trailing twelve-month figure through Dec 2025 stood at $16.7 billion (down 2.52% YoY), and the FY2025 full-year result was $16.2 billion, down 5.39% from the prior year.
  • Invested Capital retreated to $16.7 billion in Q4 2025 per GIFLF's latest filing, from $17.2 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $20.0 billion in Q4 2023 and bottomed at $16.7 billion in Q4 2025.
  • Historically, Invested Capital has averaged $18.5 billion across 5 years, with a median of $19.2 billion in 2022.
  • The sharpest annual moves came in 2021 and 2024: Invested Capital increased 19.11% in 2021, then retreated 14.16% in 2024.
  • Over 5 years, Invested Capital stood at $19.5 billion in 2021, then slipped by 1.51% to $19.2 billion in 2022, then gained by 3.91% to $20.0 billion in 2023, then decreased by 14.16% to $17.2 billion in 2024, then decreased by 2.52% to $16.7 billion in 2025.
  • According to Business Quant data, Invested Capital over the past three periods registered $16.7 billion, $17.2 billion, and $20.0 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 74.44 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 40.49 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 33.70 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn 7.35 Bn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 26.94 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn 16.72 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 16.72 Bn
Dec 31, 2024 17.15 Bn
Dec 31, 2023 19.98 Bn
Dec 31, 2022 19.23 Bn
Dec 31, 2021 19.52 Bn
Dec 31, 2020 16.39 Bn
Sep 30, 2020 16.54 Bn
Mar 31, 2020 15.90 Bn
Dec 31, 2019 15.56 Bn
Sep 30, 2019 14.03 Bn
Dec 31, 2018 12.64 Bn
Sep 30, 2018 12.23 Bn
Jun 30, 2018 12.17 Bn
Mar 31, 2018 14.83 Bn
Dec 31, 2017 11.41 Bn
Jun 30, 2017 10.74 Bn
Dec 31, 2016 9.35 Bn
Sep 30, 2016 9.20 Bn
Jun 30, 2016 9.19 Bn
Mar 31, 2016 8.52 Bn